Mumbai-based Entod Pharmaceuticals said on Thursday that it has decided to move the court to challenge the national drug regulator’s suspension of permission to manufacture and market its pilocarpine ...

The claims made by Entod Pharmaceuticals about PresVu eye drops came under scrutiny for being unapproved and potentially misleading. According to the suspension order copy accessed by News18, the ...

On September 4, the drug regulator had asked for an explanation from the company for the claims it made in the press following which the drug-maker also submitted its response.

The Drugs Controller General of India (DCGI) stated in an order dated September 10 that the Directorate had approved on August 20 for the production and distribution of Pilocarpine Hydrochloride ...

In response to the various alleged misleading claims made by Entod Pharma in respect to its Opthalmologic product, Drugs ...

Entod Pharma to challenge DCGI's suspension of permission for PresVu in court: Our Bureau, New Delhi Thursday, September 12, 2024, 13:45 Hrs [IST] Entod Pharmaceuticals announced ...

General public being misled by Entod Pharmaceuticals, says Drug Controller General of India. Company to challenge order ...

The Directorate General of Health Services (DGHS), under the Central Drugs Standard Control Organisation (CDSCO), has ...

Entod Pharmaceuticals denies making false claims about their new PresVu eye drops and plans to challenge the suspension by ...

The company, which was aiming for an October launch in the Indian market, said that it will challenge the suspension in court ...

DCGI suspends Entod Pharma`s eye drop permission for presbyopia treatment due to unapproved claims. The company will ...

The Central Drugs Standard Control Organisation (CDSCO) said that it was suspending its approval for the pilocarpine ...